United States

People: Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

28 Apr 2017
Change (% chg)

$3.03 (+2.88%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

McGinley, Michael 

Dr. Michael J. McGinley, Ph.D., is President - Biologicals & Pharmaceuticals of Heska Corporation, since February 2013. He previously served as President and Chief Operating Officer from January 2009 to February 2013, Vice President, Global Operations from April through December 2008, Vice President, Operations and Technical Affairs and General Manager, Heska Des Moines from January 2002 to April 2008 and in other positions beginning in June 1997. Prior to joining the Company, Dr. McGinley held positions with Bayer Animal Health and Fort Dodge Laboratories. He holds Ph.D. and M.S. degrees in Immunobiology from Iowa State University and successfully completed the Advanced Management Program at the Harvard Business School in 2008.

Basic Compensation

Total Annual Compensation, USD 300,105
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 201,174
Fiscal Year Total, USD 501,279

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --